Article
Monoclonal Antibodies against Zika Virus NS1 Protein Confer Protection via FcγReceptor-Dependent and -Independent Pathways
8 Feb 2021
Abstract excerpt
Zika virus (ZIKV) is a mosquito-borne flavivirus that has been linked to congenital microcephaly during recent epidemics. No licensed antiviral drug or vaccine is available. Monoclonal antibodies (MAbs) against the nonstructural protein 1 (NS1) inhibit ZIKV pathogenicity but do not enhance the disease as envelope protein-targeted MAbs do. However, the protection mechanisms are not fully understood. Here, we show...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
